Tag Archives: EU

Europe Unites Over Counterfeiting

By Guest Blogger | Published: February 28, 2011
Imitation may the sincerest form of flattery, but it isn’t always welcome. Particularly when the imitations are fakes through and through. That explains why Europe’s new rules to combat counterfeit medicines are winning such widespread applause, says Reflector. It isn’t customary for European Union legislation to win backing from all sides. Usually, there’s a large rump [...]
Posted in Europe, Global, Guest Blog, Supply Chain | Also tagged , | Leave a comment

Croatia: A New Hope for European Pharma?

By Guest Blogger | Published: February 24, 2011
With Croatia’s potential accession to the EU gathering pace, Beth Kennedy looks at the implications for pharma. The growth in overall healthcare expenditure in Croatia is slow and the percentage of GDP is expected to remain the same, but the country’s accession to the EU means that European pharma would have access to cheap products [...]
Posted in Emerging Markets, Europe, Global, Guest Blog, Market Access, healthcare | Also tagged , | Leave a comment

Innovators: Take a Leaf from the Generic Industry Book

By Guest Blogger | Published: February 1, 2011
No-one can accuse the European generic industry of indolence. It supplies huge quantities of medicines to European healthcare suppliers — its volume is estimated at around a half of the market. It is accounting for a growing share of marketing authorization applications in Europe. And its industry association, the EGA, has turned it from being [...]
Posted in Europe, Regulatory, healthcare | Also tagged , , , , , , , | Leave a comment

Exclusive Interview: The European Medicine Agency's Thomas Lönngren

By William Looney | Published: December 14, 2010
The European Medicines Agency (EMA) is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. In return, EMA has made a virtue of necessity. It filled the regulatory [...]
Posted in Europe, Global, People, Regulatory, leadership | Also tagged , , , | 2 Comments

Compliance and Disclosure Risks on Anti-Competitive Promotional Spend: Is EuroLand Set to Follow the US?

By William Looney | Published: November 24, 2010
New Cegedim survey documents whether European industry is ready for the challenge. Making sense of the promotional spend and anti-corruption compliance burden is emerging as a key strategic issue for pharma — not just in the US but in the global market space as well, where regulatory safeguards are still porous. New survey research just published [...]
Posted in Global, Legal, Regulatory, compliance | Also tagged , , , , | 1 Comment